Patent · US Active

Extended release venlafaxine formulation

US7931915B2 · kind B2 · utility

0Cited by

27References

10Claims

0Family size

Assignee

Andrx Pharmaceuticals, Inc. · US

Inventors

Manesh Dixit · Sunrise, US
Xiu Xiu Cheng · Pembroke Pines, US
Avinash Nangia · Weston, US
Chih-Ming Chen · Taipei, TW

Key dates

Filing date	Nov 19, 2008
Grant date	Apr 26, 2011
Priority date	—
Expiry date	Nov 19, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/5047
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.